RCEL - WB CGC among premarket losers November, 14 2019 09:21 AM Avita Medical Inc. VistaGen Therapeutics (NASDAQ:VTGN) -67% on reporting Phase 2 results for AV-101 as a treatment of major depressive disorder.More news on: VistaGen Therapeutics, Inc., Pacific Coast Oil Trust, Ideanomics, Inc., Stocks on the move, Read more ...